Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
guanxin suhe capsules
- Development stage
- Unknown
- Lead developer
- Tianjin Hong Ren Tang Pharmaceutical
- Administration
- Oral
01
Overview
Guanxin Suhe Capsules is a traditional Chinese medicine (TCM) product developed and manufactured by Tianjin Hong Ren Tang Pharmaceutical. It is primarily indicated for the treatment of coronary heart disease and angina pectoris. The formulation is based on a classic aromatic TCM recipe designed to warm the heart, regulate qi, and alleviate pain. It typically consists of five key ingredients: Styrax (Suhexiang), Borneol (Bingpian), Sandalwood (Tanxiang), Dalbergia wood (Jiangxiang), and Frankincense (Ruxiang). Pharmacologically, the capsules act by dilating coronary arteries, increasing coronary blood flow, and reducing myocardial oxygen consumption. It also exhibits anti-platelet aggregation properties, which help prevent thrombus formation. Clinically, it is used to relieve chest pain and pressure associated with cold stagnation and qi obstruction in the chest.
- Brand names
- Guanxin Suhe Capsules冠心苏合胶囊
- Other names
- Guanxin Suhe Jiaonang
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)CASP3 (Caspase-3)CCL2 (C-C motif chemokine 2)IL8 (C-X-C Motif Chemokine Ligand 8)EGFR (Epidermal growth factor receptor)IL10 (Interleukin-10)IL-6 (Interleukin 6)JUN (Transcription factor Jun)MAPK14 (p38 mitogen-activated protein kinase alpha)MMP9 (Matrix metalloproteinase-9)NOS2 (Nitric Oxide Synthase 2)RELA (Nuclear Factor Kappa B Subunit p65)STAT3 (Signal Transducer and Activator of Transcription 3)TP53 (Cellular Tumor Antigen p53 R175H)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on guanxin suhe capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on guanxin suhe capsules.